Neutralizing anti-IFN-beta antibodies: how much more evidence do we need to use them in practice?
Giovannoni
Gavin
G
Goodman
Andrew
A
D001323:Autoantibodies / Q000276:immunology*; D018450:Disease Progression; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects* / Q000276:immunology*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D055502:Secondary Prevention; D016896:Treatment Outcome
D001323:Autoantibodies; D016899:Interferon-beta